"Infusions, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it.
| Descriptor ID |
D007262
|
| MeSH Number(s) |
E02.319.267.082.500 E02.319.267.510.590
|
| Concept/Terms |
Intravenous Drip- Intravenous Drip
- Drip, Intravenous
- Drip Infusions
- Drip Infusion
- Infusion, Drip
- Infusions, Drip
|
Below are MeSH descriptors whose meaning is more general than "Infusions, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Infusions, Intravenous".
This graph shows the total number of publications written about "Infusions, Intravenous" by people in this website by year, and whether "Infusions, Intravenous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 8 | 9 |
| 1995 | 0 | 13 | 13 |
| 1996 | 0 | 11 | 11 |
| 1997 | 1 | 8 | 9 |
| 1998 | 0 | 15 | 15 |
| 1999 | 0 | 13 | 13 |
| 2000 | 0 | 12 | 12 |
| 2001 | 0 | 16 | 16 |
| 2002 | 0 | 16 | 16 |
| 2003 | 0 | 8 | 8 |
| 2004 | 0 | 7 | 7 |
| 2005 | 0 | 11 | 11 |
| 2006 | 0 | 13 | 13 |
| 2007 | 0 | 4 | 4 |
| 2008 | 1 | 9 | 10 |
| 2009 | 0 | 14 | 14 |
| 2010 | 0 | 5 | 5 |
| 2011 | 0 | 12 | 12 |
| 2012 | 1 | 8 | 9 |
| 2013 | 0 | 10 | 10 |
| 2014 | 0 | 11 | 11 |
| 2015 | 0 | 5 | 5 |
| 2016 | 0 | 7 | 7 |
| 2017 | 0 | 7 | 7 |
| 2018 | 1 | 7 | 8 |
| 2019 | 0 | 8 | 8 |
| 2020 | 0 | 10 | 10 |
| 2021 | 0 | 2 | 2 |
| 2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Infusions, Intravenous" by people in Profiles.
-
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis. N Engl J Med. 2024 Sep 26; 391(12):1119-1129.
-
Intravenous Versus Intraosseous Use of Tranexamic Acid in Patients With Traumatic Brain Injury. J Surg Res. 2024 Oct; 302:798-804.
-
Safety and feasibility of intravenous sotalol loading for the prevention of ventricular arrhythmias. J Interv Card Electrophysiol. 2024 Oct; 67(7):1647-1655.
-
Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative. J Stroke Cerebrovasc Dis. 2021 Dec; 30(12):106121.
-
Early Convalescent Plasma for High-Risk Outpatients with Covid-19. N Engl J Med. 2021 11 18; 385(21):1951-1960.
-
A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection. N Engl J Med. 2021 07 29; 385(5):436-444.
-
Changes in Cancer Management due to COVID-19 Illness in Patients with Cancer in Northern California. JCO Oncol Pract. 2021 Mar; 17(3):e377-e385.
-
Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury. J Trauma Acute Care Surg. 2020 11; 89(5):900-907.
-
Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury. JAMA. 2020 09 08; 324(10):961-974.
-
Evaluation of an Intrapartum Insulin Regimen for Women With Diabetes. Obstet Gynecol. 2020 08; 136(2):411-416.